Source: PR Newswire
I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs for cell therapy in a palm-size closed cassette.
Source: Healthline
As the world of stem cell research advances, more options may become available to patients with RA and other autoimmune diseases.
Source: Pain News Network
A Canadian doctor is recruiting patients for a "first of its kind" stem cell research project for osteoarthritis. The Phase II study could further advance the use of regenerative medicine in treating osteoarthritis, a joint disease for which treatment options are currently limited to pain medication, steroid injections or joint replacement surgery.
Source: News-Medical.Net
In new research from the Wake Forest Institute for Regenerative Medicine (WFIRM), scientists have shown that bioengineered uteri supported fertilization, fetal development, and live birth with normal offspring.
Source: Genetic Engineering & Biotechnology News
According to the American Society of Gene & Cell Therapy, regenerative medicine may be defined as a branch of medicine that aims to repair damaged tissue. “Repair” may involve the replacement or regeneration of human cells, tissues, or organs.
Source: News-Medical.Net
Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.
Source: Mining Journal
Amniotic materials have many applications in medicine, especially sports medicine. The beneficial properties of amniotic fluid have it poised to become a major player in the healthcare market, especially with the trend-setter, Medicare, leading the way.